Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

DOACs look safe in elective endoscopic procedures

Publish date:: December 31, 2020

Key clinical point: Risk of bleeding and thromboembolic events with direct oral anticoagulants (DOACs) was similar to that with vitamin K antagonists (VKAs).

Major finding: Patients on DOACs and VKAs had similar rates of perioperative bleeding (6.7% vs. 6.2%) and thromboembolic events (1.5% vs. 1.3%).

Study details: Multicenter, prospective observational study of 1,623 patients at 12 Spanish academic and community centers.

Disclosures: The study was funded by the Spanish Society of Gastrointestinal Endoscopy. Dr. Sealock has no relevant financial disclosures.

Citation:

de Santiago ER et al. Clin Gastroenterol Hepatol. 2020 Dec 03. doi: 10.1016/j.cgh.2020.11.037.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Gastroenterology

Younger adults present with more advanced esophageal adenocarcinoma,

DOACs look safe in elective endoscopic procedures,

Upper GI bleeds in COVID-19 not related to increased mortality,

Cryoballoon, cryospray found equivalent for eradicating Barret’s esophagus,